1. CD8+ T‐cell recognition of a synthetic epitope formed by t‐butyl modification. Issue 3 (March 2015) Authors: Reid, Reiss A.; Redman, James E.; Rizkallah, Pierre; Fegan, Chris; Pepper, Chris; Man, Stephen Journal: Immunology Issue: Volume 144:Issue 3(2015:Mar.) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical utility of telomere length measurements in cancer. (February 2020) Authors: Pepper, Chris; Norris, Kevin; Fegan, Christopher Journal: Current opinion in genetics & development Issue: Volume 60(2020) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Heart disease and the surgical patient. (©2007) Other Names: Howell, Simon J; Pepper, Chris; Spahn, Donat R Record Type: Book Extent: 1 online resource (x, 386 pages), illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hydroxybenzoate magnesium analogues induced apoptosis in HT-1080 human fibrosarcoma cells. Issue 1 (2019) Authors: Manning, Abigail J; Mahdi, Eamon J; Pepper, Andrea GS; Pepper, Chris; Al-Musayeib, Nawal M; Mahdi, Jassem G Journal: Clinical sciences research and reports Issue: Volume 2:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLL. (8th November 2019) Authors: Elston, Lauren; Fegan, Chris; Hills, Robert; Hashimdeen, Shaikh S.; Walsby, Elisabeth; Henley, Peter; Pepper, Chris; Man, Stephen Journal: British journal of haematology Issue: Volume 188:Number 6(2020) Page Start: 872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is venetoclax a new wonder drug in CLL?. (11th March 2019) Authors: Fegan, Chris; Pepper, Chris Journal: British journal of haematology Issue: Volume 185:Number 4(2019) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Managing drug-induced QT prolongation in clinical practice. Issue 1149 (29th October 2020) Authors: Khatib, Rani; Sabir, Fatima R N; Omari, Caroline; Pepper, Chris; Tayebjee, Muzahir Hassan Journal: Postgraduate medical journal Issue: Volume 97:Issue 1149(2021) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. NF-κκB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia. (September 2009) Authors: Pepper, Chris; Hewamana, Saman; Brennan, Paul; Fegan, Chris Journal: Future oncology Issue: Volume 5:Number 7(2009) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry. Issue 3 (21st September 2016) Authors: Betts, Timothy R.; Leo, Milena; Panikker, Sandeep; Kanagaratnam, Prapa; Koa‐Wing, Michael; Davies, David Wyn; Hildick‐Smith, David; Wynne, Dylan G.; Ormerod, Oliver; Segal, Oliver R.; Chow, Anthony W.; Todd, Derick; Cabrera Gomez, Sandra; Kirkwood, Graeme J.; Fox, David; Pepper, Chris; Foran, Joh... Journal: Catheterization and cardiovascular interventions Issue: Volume 89:Issue 3(2017) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Shortened telomeres: a driving force behind leukemia?. (November 2010) Authors: Pepper, Chris; Baird, Duncan M Journal: Future oncology Issue: Volume 6:Number 11(2010) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗